Palatin Technologies Inc (PTN)
1.16
+0.07
(+6.42%)
USD |
NYAM |
Nov 07, 16:00
1.16
0.00 (0.00%)
After-Hours: 20:00
Palatin Technologies Revenue (Annual): 4.490M for June 30, 2024
Revenue (Annual) Chart
Historical Revenue (Annual) Data
Date | Value |
---|---|
June 30, 2024 | 4.490M |
June 30, 2023 | 4.854M |
June 30, 2022 | 1.468M |
June 30, 2021 | -0.1886M |
June 30, 2020 | 0.118M |
June 30, 2019 | 60.30M |
June 30, 2018 | 67.13M |
June 30, 2017 | 44.72M |
June 30, 2016 | |
June 30, 2015 | 12.95M |
June 30, 2014 | |
June 30, 2013 | 0.0104M |
June 30, 2012 | 0.0737M |
June 30, 2011 | 1.476M |
June 30, 2010 | 14.18M |
Date | Value |
---|---|
June 30, 2009 | 11.35M |
June 30, 2008 | 11.48M |
June 30, 2007 | 14.41M |
June 30, 2006 | 19.75M |
June 30, 2005 | 17.96M |
June 30, 2004 | 2.315M |
June 30, 2003 | 1.27M |
June 30, 2002 | 0.2814M |
June 30, 2001 | 1.788M |
June 30, 2000 | 5.117M |
June 30, 1999 | 0.61M |
June 30, 1998 | 0.034M |
June 30, 1997 | 0.70M |
June 30, 1996 | 0.0245M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
-0.1886M
Minimum
2021
4.854M
Maximum
2023
2.148M
Average
1.468M
Median
2022
Revenue (Annual) Benchmarks
NovaBay Pharmaceuticals Inc | 14.73M |
iBio Inc | 0.225M |
Theriva Biologics Inc | -- |
Oragenics Inc | -- |
Nanoviricides Inc | -- |